Share on StockTwits

Immucell Corp (NASDAQ:ICCC) Director Jonathan E. Rothschild bought 3,000 shares of the company’s stock in a transaction dated Wednesday, August 20th. The shares were purchased at an average cost of $4.55 per share, for a total transaction of $13,650.00. Following the completion of the acquisition, the director now directly owns 513,436 shares of the company’s stock, valued at approximately $2,336,134. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Shares of Immucell Corp (NASDAQ:ICCC) traded down 1.05% during mid-day trading on Monday, hitting $4.70. The stock had a trading volume of 1,700 shares. Immucell Corp has a one year low of $3.30 and a one year high of $5.30. The stock has a 50-day moving average of $4.63 and a 200-day moving average of $4.40. The company’s market cap is $14.2 million.

Immucell Corp (NASDAQ:ICCC) last released its earnings data on Tuesday, August 12th. The company reported ($0.10) EPS for the quarter. The company had revenue of $1.54 million for the quarter, compared to the consensus estimate of $1.37 million.

ImmuCell Corporation creates scientifically proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries.

Receive News & Ratings for Immucell Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immucell Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.